Northern Trust
TNGX icon

Northern Trust’s Tango Therapeutics TNGX Stock Holding History

Northern Trust’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.5M Buy
1,231,933
+368,993
+43% +$9.12M ﹤0.01% 1375
2026
Q1 		$18.1M Buy
862,940
+59,741
+7% +$832K ﹤0.01% 1739
2025
Q4 		$7.12M Buy
803,199
+197,638
+33% +$1.7M ﹤0.01% 2267
2025
Q3 		$5.09M Buy
605,561
+5,053
+0.8% +$34.2K ﹤0.01% 2494
2025
Q2 		$3.07M Buy
600,508
+151,126
+34% +$374K ﹤0.01% 2754
2025
Q1 		$616K Sell
449,382
-63,697
-12% -$156K ﹤0.01% 3490
2024
Q4 		$1.59M Buy
513,079
+33,829
+7% +$157K ﹤0.01% 3150
2024
Q3 		$3.69M Buy
479,250
+87,674
+22% +$837K ﹤0.01% 2648
2024
Q2 		$3.36M Sell
391,576
-9,553
-2% -$73.8K ﹤0.01% 2617
2024
Q1 		$3.18M Sell
401,129
-11,275
-3% -$121K ﹤0.01% 2740
2023
Q4 		$4.08M Buy
412,404
+10,963
+3% +$95.2K ﹤0.01% 2621
2023
Q3 		$4.52M Buy
401,441
+14,945
+4% +$91.1K ﹤0.01% 2510
2023
Q2 		$1.28M Sell
386,496
-11,998
-3% -$43.2K ﹤0.01% 3251
2023
Q1 		$1.57M Sell
398,494
-10,239
-3% -$59.4K ﹤0.01% 3043
2022
Q4 		$2.96M Sell
408,733
-8,037
-2% -$56.5K ﹤0.01% 2784
2022
Q3 		$1.51M Sell
416,770
-18,804
-4% -$80.3K ﹤0.01% 3151
2022
Q2 		$1.97M Buy
435,574
+314,019
+258% +$1.9M ﹤0.01% 3076
2022
Q1 		$921K Sell
121,555
-3,005
-2% -$26K ﹤0.01% 3455
2021
Q4 		$1.36M Buy
124,560
+11,410
+10% +$137K ﹤0.01% 3412
2021
Q3 		$1.46M Buy
+113,150
New +$1.36M ﹤0.01% 3415

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Northern Trust's TNGX Position: Q2 2026 in Review

Northern Trust increased its Tango Therapeutics (TNGX) stake by 43% in Q2 2026, buying an estimated $9.12M and bringing the position to 1,231,933 shares worth $38.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1375.

Northern Trust first reported a position in TNGX in Q3 2021 and has held it in 20 quarters since. 248 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Northern Trust held 1,231,933 shares of Tango Therapeutics worth $38.5M as of Q2 2026.
  • Northern Trust bought 368,993 Tango Therapeutics shares in Q2 2026, an estimated $9.12M.
  • Tango Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #1375 holding.
  • Northern Trust first reported a position in Tango Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • 248 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.